Many adults aged 60 years or older take thyroid hormone medication for life. However, long-term use is not always necessary for everyone. A recent study investigated levothyroxine discontinuation in elderly patients. Researchers conducted a prospective trial involving 370 participants in the Netherlands. They aimed to determine who could safely stop treatment while maintaining normal thyroid function. These findings provide vital evidence for clinicians managing thyroid health in older populations.

Successful Levothyroxine Discontinuation in Elderly

Specifically, the study reported that 25.7% of participants successfully stopped taking levothyroxine. These individuals maintained stable thyrotropin (TSH) and free thyroxine (fT4) levels for one year. Notably, the success rate jumped to 63.6% for those taking a dose of 50 µg/day or lower. Furthermore, thyroid-related quality of life did not change significantly after stopping the drug. This suggests that many patients do not experience negative symptoms when they deprescribe thyroid hormones. Consequently, doctors should consider evaluating the need for ongoing therapy in older adults.

Moreover, the protocol involved a stepwise dose reduction rather than immediate cessation. This cautious approach ensures patient safety and allows for regular laboratory monitoring. Additionally, the study included community-dwelling adults who had stable dosages for at least one year. These results highlight a significant opportunity to reduce polypharmacy and avoid potential overtreatment. Therefore, clinicians should prioritize TSH evaluation for those on low-dose supplementation. Identifying suitable candidates for discontinuation can improve overall geriatric care and health outcomes.

Frequently Asked Questions

Can all older adults stop taking thyroid medication?

No, discontinuation is not suitable for every patient. This study focused on adults 60 or older with stable low doses and TSH levels below 10 mIU/L. Always consult a physician before changing or stopping your dosage.

What dosage makes discontinuation more likely to succeed?

Patients on a levothyroxine dose of 50 µg/day or lower have a much higher success rate. In this trial, over 60% of those on low doses successfully stopped the medication without negative effects.

Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Ravensberg J et al. Discontinuation of Levothyroxine in Adults Aged 60 Years or Older. JAMA. 2026 Apr 06. doi: 10.1001/jama.2026.2864. PMID: 41941226.


2. Biondi B, Cooper DS. Subclinical Hypothyroidism in Older Individuals. Lancet Diabetes Endocrinol. 2022.


3. Thayumana FK, et al. Clinical Outcomes after Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis. Thyroid. 2021.